Neuropletic malignant syndrome and olanzapine.
Sierra-Biddle
D
D
Herran
A
A
Diez-Aja
S
S
Gonzalez-Mata
J M
JM
Vidal
E
E
Diez-Manrique
F
F
Vazquez-Barquero
J L
JL
D000328:Adult; D014150:Antipsychotic Agents / Q000009:adverse effects*; D001569:Benzodiazepines; D005260:Female; D006801:Humans; D009459:Neuroleptic Malignant Syndrome / Q000209:etiology*; D000077152:Olanzapine; D010890:Pirenzepine / Q000009:adverse effects / Q000031:analogs & derivatives*; D012559:Schizophrenia / Q000188:drug therapy
D014150:Antipsychotic Agents; D001569:Benzodiazepines; D010890:Pirenzepine; D000077152:Olanzapine